Biotech & Healthcare TV



FinCanna Capital Corp.
Latest Comments
image_pdfimage_print
 

GCAC’s Bratter on building an international databank of medicinal cannabis patient efficacy information


June 01, 2018
| June 01, 2018

June 1, 2018 – “At GCAC we are building an international databank of medicinal cannabis patient efficacy information, which will be […]


 

Cannabis and Blockchain, the CSE’s record breaking year


May 31, 2018
| May 31, 2018

May 31, 2018 – “I am here to give you an update on the CSE. In a word we are busy. […]


 

Scythian CEO on the potential impact of cannabinoid drugs on traumatic brain injuries


August 29, 2017
| August 29, 2017 | 1 Comment

Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with […]


 

BlueOcean’s founder on astaxanthin – the “next wonder antioxidant”


March 14, 2017
| March 14, 2017 | 1 Comment

Sam Kanes, VP of Strategy and Investor Relations for BlueOcean NutraSciences Inc. (TSXV: BOC) in an interview with InvestorIntel’s CEO […]


 

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal


January 09, 2017
| January 09, 2017

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX |OTCQX: IGXT), discusses […]


 

IntelGenx CEO speaks to the potential impact of Montelukast on Alzheimers


January 03, 2017
| January 03, 2017

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX | OTCQX: IGXT) […]


FinCanna Capital Corp.